AzTrials
AzTrials

RV PacingNCT04908033

Ultra-high-frequency ECG for Prediction of Left Ventricular Remodeling

An observational study of RV Pacing and Negative Remodeling, run by Faculty Hospital Kralovske Vinohrady at 1 site in Czechia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main goal of the project is to prove that ultra-high-frequency ECG (UHF-ECG) can be used as a diagnostic tool that allows the prediction of patients susceptible to the negative effect of right ventricular myocardial pacing. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
RV Pacing, Negative Remodeling, Dyssynchrony
What is being tested?
pacemaker implantation
Type of treatment
Medical device
How many people
368 participants
Where
1 siteCzechia
Study dates
1 May 2021to 1 Dec 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 360 patients with an indication for permanent pacing due to permanent conduction disease of/below the AV node

Who may be able to join

  • expectation of permanent right ventricular pacing with atrio-ventricular delay set to 150/180 ms (130/160 resp.) for sensed/paced atrial events during a follow-up,
  • a good quality of images during echocardiography,
  • willingness to attend clinical check-ups in the implanting center for at least two years.
  • life expectancy of at least 2 years

Who cannot join

  • planned cardiac surgery or transcatheter aortic valve implantation
  • hypertrophic cardiomyopathy
  • an indication for implantable cardioverter-defibrillator, biventricular implantable cardioverter-defibrillator, or biventricular pacemaker
  • active myocarditis
  • cardiac surgery or coronary revascularization in the last ten days
  • persistent/permanent atrial fibrillation during randomization
  • severe aortic stenosis
  • mitral valvular disease with an indication to intervention.

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • Karol Curila

    Prague, 10000

Other trials in Czechia

About this study

Official title: Ultra-high-frequency ECG for Prediction of Adverse Left Ventricular Remodeling in Permanent Right Ventricular Pacing

The main goal of the project is to prove that ultra-high-frequency ECG (UHF-ECG) can be used as a diagnostic tool that allows the prediction of patients susceptible to the negative effect of right ventricular myocardial pacing. The prediction will be based on the assessment of electrical dyssynchrony and local depolarization durations of left ventricular depolarization emerging during right ventricular pacing. If proved to be valid in left ventricular negative remodeling prediction, UHF-ECG-derived parameters of ventricular dyssynchrony could be used as markers allowing a lead placement optimization during an implant procedure. This information can help the operator to identify patients with the urgent need for physiological pacing (HB or LBBp) and patients in which a right ventricular myocardial pacing is sufficient and will not lead to the development of the negative left ventricular remodeling.

Being tested
pacemaker implantation
Keywords
myocardial pacing, physiological pacing, negative remodeling, dyssynchrony, ultra-high-frequency ECG

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pacemaker implantationDevice

    pacemaker implantation

Study groups in NCT04908033
Study groupRoleWhat they receive
myocardial pacing grouppatients with the pacing lead placed into the right ventricle to obtain myocardial capture
Receives: Device: pacemaker implantation
physiological pacing grouppatients with the pacing lead placed into the His bundle or left bundle branch area
Receives: Device: pacemaker implantation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. negative remodeling prediction

    • 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG electrical dyssynchrony parameter
    • 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter
    • 5% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter
    • 10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG left ventricular lateral wall delay parameter
    • 10% drop in the left ventricular ejection fraction will be predicted by the duration of UHF-ECG V6d parameter

    Measured: 1 year from randomization

Secondary outcomes (2)
  1. RV myocardial to physiological pacing comparison

    left ventricular ejection fraction comparison between low risk right ventricular myocardial to physiological pacing group

    Measured: 2 years from randomization

  2. UHF-ECG prediction of clinical outcome

    occurence of death, myocardial infarction, worsening heart failure or upgrade to resynchronization therapy will be predicted by the duration of UHF-ECG electrical dyssynchrony, and/or left ventricular lateral wall delay and/or V6d parameter

    Measured: 3 years from randomization

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jun 2021
  2. Study start1 May 2021
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
368 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04908033
Sponsor's protocol ID
EK-VP1421012
Status last verified
Mar 2024
First submitted
15 May 2021
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of RV Pacing and Negative Remodeling, run by Faculty Hospital Kralovske Vinohrady at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

negative remodeling prediction (time frame: 1 year from randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in